Mixed dementia: emerging concepts and therapeutic implications.
Kenneth M Langa1, Norman L Foster, Eric B Larson
1Division of General Medicine, Department of Medicine, University of Michigan Medical School, Ann Arbor, USA. klanga@umich.edu
JAMA
|December 16, 2004
Summary
Mixed dementia, combining Alzheimer disease (AD) and vascular dementia (VaD), has limited medication benefits. Managing cardiovascular risk factors is key for prevention and slowing progression.
Area of Science:
- Neurology
- Geriatrics
- Pharmacology
Background:
- Mixed dementia, the co-occurrence of Alzheimer disease (AD) and vascular dementia (VaD), is increasingly prevalent due to aging populations.
- Understanding the interplay between AD and VaD is crucial for effective management.
Purpose of the Study:
- To review the diagnosis, pathophysiology, and interaction of AD and VaD in mixed dementia.
- To systematically review evidence for pharmacologic therapies in mixed dementia.
Main Methods:
- Searched Cochrane Database of Systematic Reviews for 'dementia'.
- Searched MEDLINE for English articles (last 10 years) on 'mixed dementia', 'Alzheimer disease' + 'cerebrovascular disorders' + 'drug therapy', and 'vascular dementia' + 'drug therapy'.
Main Results:
- Mixed dementia is common with aging, often showing coexisting AD and vascular lesions.
- Pharmacologic therapies, including cholinesterase inhibitors, offer modest benefits for mixed dementia, comparable to AD treatment.
- Managing cardiovascular risk factors like hypertension is a promising strategy for prevention and slowing progression.
Conclusions:
- Current medications offer limited clinical benefits for established mixed dementia.
- Controlling cardiovascular risk factors (hypertension, hyperlipidemia) and preventing stroke are vital for managing mixed dementia.
- Further research is needed to align treatment goals with patient and family expectations and optimize medication use.
Related Concept Videos
Taste Buds and Receptors
5.6K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
5.6K
Psychosis: Goals of Pharmacotherapy
706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Theoretical Approaches to Psychological Disorder
1.1K
The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
1.1K
Positive Symptoms Schizophrenia: Hallucinations and Delusions
1.1K
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
1.1K
Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449


